- Home
- FATE vs WNEB Comparison
FATE vs WNEB Comparison
Compare FATE & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FATE | WNEB |
|---|---|---|
| Founded | 2007 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.0M | 264.8M |
| IPO Year | 2013 | 2001 |
Fundamental Metrics
Financial Performance| Metric | FATE | WNEB |
|---|---|---|
| Price | $2.07 | $14.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 3 |
| Target Price | $5.74 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.1M | 33.0K |
| Earning Date | 11-16-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 2.03% |
| EPS Growth | 29.88 | ★ 33.93 |
| EPS | N/A | ★ 0.42 |
| Revenue | ★ $6,646,000.00 | $44,000.00 |
| Revenue This Year | N/A | $11.31 |
| Revenue Next Year | N/A | $8.11 |
| P/E Ratio | ★ N/A | $32.86 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.95 | $11.32 |
| 52 Week High | $3.23 | $15.01 |
Technical Indicators
Market Signals| Indicator | FATE | WNEB |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 50.39 |
| Support Level | $1.78 | $13.38 |
| Resistance Level | $2.15 | $14.13 |
| Average True Range (ATR) | 0.13 | 0.32 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 60.42 | 45.57 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.